FDA Criticized For “Shamefully” Approving Vaccine For Infants

FDA Criticized For “Shamefully” Approving Vaccine For Infants


The Food and Drug Administration (FDA) approved the MenQuadfi meningococcal quadrivalent conjugate vaccine, manufactured by Sanofi, for infants six weeks to two years old.

The vaccine had previously gained approval for individuals two years and older.

The #FDA has approved MenQuadfi for infants as young as 6 weeks, making it the only MenACWY vaccine available from this age and enhancing early protection against invasive #meningococcal disease caused by serogroups A, C, W, and Y.

Read more using the link in the replies below. pic.twitter.com/clg0MamdxS

Trending: Fauci Must Be Shaken to the Core After Latest Discovery in COVID Investigation: They Found It

— Pharmacy Times (@Pharmacy_Times) June 3, 2025

“Invasive meningococcal disease (IMD) remains a major global health challenge because it can strike quickly and with devastating effects, potentially taking a life in less than 24 hours. As infants continue

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!